Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Gane

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Journal of Paediatrics and Child Health|January 30, 2023
Atopy and allergy following solid organ transplantation: A 15-year experienceAmin J Roberts, Alicia Lim, Jonathan R Bishop, et al.
Antiviral Therapy|November 21, 2025
A Phase 1 study of the safety, tolerability, and pharmacokinetics of ALG-000184 (pevifoscorvir sodium), a novel Class E capsid assembly modulator, in healthy participantsEd Gane, Christian Schwabe, Min Wu, et al.
Hepatology (Baltimore, Md.)|April 9, 2014
Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimensZobair M Younossi, Maria Stepanova, Fatema Nader, et al.
World Journal of Surgery|July 5, 2007
Liver resection for hepatocellular carcinoma in a hepatitis B endemic areaAdam St J R Bartlett, John L McCall, Jonathan B Koea, et al.
Journal of Gastroenterology and Hepatology|August 8, 2015
The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New ZealandJessica Howell, Glenda Balderson, Margaret Hellard, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 6, 2018
Effects of Treatment of Chronic Hepatitis B Virus Infection on Patient-Reported OutcomesZobair M Younossi, Maria Stepanova, Harry L A Janssen, et al.
Nature Reviews. Gastroenterology & Hepatology|January 11, 2023
The scientific basis of combination therapy for chronic hepatitis B functional cureSeng Gee Lim, Thomas F Baumert, Carolina Boni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2019
Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replicationZobair M Younossi, Maria Stepanova, Issah Younossi, et al.
Journal of Gastroenterology and Hepatology|August 29, 2018
Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030Jess Howell, Alisa Pedrana, Benjamin C Cowie, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2019
Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinomaSandrine Faivre, Armando Santoro, Robin K Kelley, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Journal of Paediatrics and Child Health|January 30, 2023
Atopy and allergy following solid organ transplantation: A 15-year experienceAmin J Roberts, Alicia Lim, Jonathan R Bishop, et al.
Antiviral Therapy|November 21, 2025
A Phase 1 study of the safety, tolerability, and pharmacokinetics of ALG-000184 (pevifoscorvir sodium), a novel Class E capsid assembly modulator, in healthy participantsEd Gane, Christian Schwabe, Min Wu, et al.
Hepatology (Baltimore, Md.)|April 9, 2014
Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimensZobair M Younossi, Maria Stepanova, Fatema Nader, et al.
World Journal of Surgery|July 5, 2007
Liver resection for hepatocellular carcinoma in a hepatitis B endemic areaAdam St J R Bartlett, John L McCall, Jonathan B Koea, et al.
Journal of Gastroenterology and Hepatology|August 8, 2015
The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New ZealandJessica Howell, Glenda Balderson, Margaret Hellard, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 6, 2018
Effects of Treatment of Chronic Hepatitis B Virus Infection on Patient-Reported OutcomesZobair M Younossi, Maria Stepanova, Harry L A Janssen, et al.
Nature Reviews. Gastroenterology & Hepatology|January 11, 2023
The scientific basis of combination therapy for chronic hepatitis B functional cureSeng Gee Lim, Thomas F Baumert, Carolina Boni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2019
Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replicationZobair M Younossi, Maria Stepanova, Issah Younossi, et al.
Journal of Gastroenterology and Hepatology|August 29, 2018
Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030Jess Howell, Alisa Pedrana, Benjamin C Cowie, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2019
Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinomaSandrine Faivre, Armando Santoro, Robin K Kelley, et al.
Pageof 8